glp 1 muscle loss Sarcopenia in the era of GLP-1 receptor agonists: Implications for the internist Many People Actually Lose Muscle
Description
Biological and functional characteristics of a novel lowmolecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo
Recognising these realities is essential before committing to GLP-1-based treatment
J Hepatol (2019) 1:31228
Subsequently, cumulative food intake at 24 h after p.o
RAMP3 deficiency enhances postmenopausal obesity and metabolic disorders
Although prior studies were performed using mice, a rationale exists for future studies examining TRPA1 channel-dependent regulation of GLP-1 secretion from human L-cells
